Respiratory tract infections caused by respiratory syncytial virus in children: Diagnosis and treatment

Minerva Pediatrica

Volumn 53, Issue 2, 2001, Pages 99-106

  Van Woensel, J B M ^a   Kimpen, J L L ^b   Brand, P L P ^c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

Author keywords

Child; Respiratory Syncytial Virus; Respiratory tract infections; Therapy

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; RIBAVIRIN; VIRUS PROTEIN;

BRONCHODILATATION; CHILDHOOD DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOPATHOLOGY; IMMUNOPROPHYLAXIS; META ANALYSIS; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT INDICATION; VIRUS INFECTION;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; META-ANALYSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN;

EID: 0034943552     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973;288: 498-505.
2. Feign DF, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia: W. B. Saunders Company, 1997.
3. Ogra PL, Patel J. Respiratory syncytial virus infection and the immunocompromised host. Pediatr Infect Dis J 1988;7:246-9.
4. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC et al. Respiratory syncylial virus infection in children with compromised immune function. N Engl J Med 1986;315:77-81.
5. Kimpen JLL, Schaad UB. Treatment cf respiratory syncytial virus hronchiolitis: 1995 poll of members of the european society for paediatric infectious diseases. Pediatr Infect Dis J 1997;16:479-81.
6. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalised with respiratory syncytial virus. Eur J Pediatr 1998;157:215-20.
7. Rakshi K, Couriel IM. Management of acute bronchiolitis. Arch Dis Child 1994;71:463-9.
8. Brand PLP, Vaessen-Verberne AAPH. Differences in management of bronchiolitis between hospitals in The Netherlands. Eur J Pediatr 2000;159:343-7.
9. Hall CB, Powell KR, Schnabel KC, Gala CL Pincus PH. Risk of secondary bacterial infection in infants hospitalised with respiratory syncytial viral infection. J Pediatr 1988;113:266-71.
10. Dawson KP, Lonf A, Ennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health 1990;26:209-11.
11. Ruuskanen O, Putto A, Sarkkinen H, Meurman O, Irjala K. C-reactive protein in respiratory virus infections. J Pediatr 1985;107:97-100.
12. Saijo M, Ishii T, Kokubo M, Murono K, Takimoto M, Fujita K. White blood cell count, C-reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract. Acta Paediatr Jpn 1996;38:596-600.
13. Perlstein PH, Kotagal UR Bolling C. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104:1334-41.
14. Taber LH, Knight V, Gilbert BE, McChung HW, Wilson SZ, Norton HJ et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983;72:613-8.
15. Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985;254:3047-51.
16. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. A randomized double-blind study. N Engl J Med 1983;308:1443-7.
17. Groothuis JR, Woodin KA, Katz R, Robertson AD, McBride JT, Hall CB et al. Early ribavirin treatment of respiratory syncytial virus infection in high-risk children. J Pediatr 1990;117:792-8.
18. Janai HK, Stutman HR, Zaleska M, Rub B, Eyzaguirre M, Marks MI et al. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis Pediatr Infect Dis J 1993;12:214-8.
19. Barry W, Cockburn F, Cornall R, Price JF, Sutherland G, Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child 1986;61:593-7.
20. Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus lower respiratory tract infection. Arch Pediatr Adolesc Med 1996;150:942-7.
21. Smith DW, Frankel LR, Mathers LH, Tang ATS, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991;325:24-9.
22. Meert KL, Sarnaik AP, Gelmini M, Lieh Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 1994;22:566-72.
23. Moler FW, Steinhart CM, Ohmit SE Stidham GL. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J Pediatr 1996;128:422-8.
24. Law BJ, Wang EFL, Stephens D. Ribavirin does not reduce hospital stay (LOS) in patients with respiratory syncytial virus (RSV) lower repsiratory tract infection (LRTI). Pediatr Res 1995;37:110A.
25. Mallol J, Barrueto L, Girardi G. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol 1987;3:298-303.
26. Wang EEL, Milner R, Allen UD, Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child 1992;67:289-93.
27. Ho L, Collis G, Lindau LI, Le Souef PN. Effect of salbutamol on oxyger saturation in bronchiolitis. Arch Dis Child 1991;66:1061-4.
28. Lines DR, Kattampallil JS, Liston P. Efficacy of nebulised salbutamol in bronchiolitis. Pediatr Rev Communic 1990;5:121-9.
29. Chowdhury D, al Howasi M, Khalil M, al-Frayh AS, Chowdhury S, Ramia S. The role of bronchodilators in the management of bronchiolitis: a clinical trial. Ann Trop Paediatr 1995;15:77-84.
30. Goh A, Chay OM, Foo AL, Ong EK. Efficacy of bronchodilators in the treatment of bronchiolitis. Sing Med J 1997;38:326-8.
31. Dobson JV, Stephens-Groff SM, McMahon SR, Stemmler MM, Brailler SL., Iray C. The use of albuterol in hospitalized infants with bronchiolitis Pediatrics 1998;101:361-8.
32. Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child 1992;146:412-8.
33. Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petric M et al. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990;117:633-7.
34. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Marilyn ML. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807-11.
35. Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994;93:907-12.
36. Gadomski AM, Aref GH, el Din OB, el Sawy IH, Khallaf N, Black RE. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. J Pediatr 1994;124:131-8.
37. Schweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulized albuterol in wheezing infants. Pediatr Emer Care 1992;8:184-8.
38. Henry RL, Milnez AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983;58:925-6.
39. Lines DR, Bates ML, Rechtman AR, Sammartino LP. Efficacy of nebulised ipratropium bromide in acute bronchiolitis. Pediatr Rev Communic 1992;6:161-7.
40. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: response to epinephrine. Pediatrics 1987;79: 939-45.
41. Kristjansson S, Iodrup Carlsen KC, Wennergren G, Strannegard IL, Carlsen KH. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child 1993;69:650-4.
42. Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993;122:145-51.
43. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126:1004-7.
44. Flores G, Horwitz RI. Efficacy of beta-2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9.
45. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilator therapy in bronchiolitis. Issue 4. Oxford: Update Software, The Cochrane Library, 1998.
46. Oski FA, Salitsky S, Barness LA. Steroid therapy in bronchiolitis: a double-blind study. Am J Dis Child 1961;102:759.
47. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71:13-8.
48. Leer JA, Green JL, Heimlich EM, Hyde JS, Moffet HL, Young GA et al. Corticosteroid treatment in bronchiolitis. Am J Dis Child 1969;117:495-503.
49. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990;9:181-5.
50. Sussman S, Grossman M, Magoffin R, Shielbe J. Dexamethasone in obstructive respiratory tract infection in children. A controlled study. Pediatrics 1964;34:851.
51. Connolly JH, Field CMB, Glasgow JFT, Slattery CM, MacLynn DM. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand 1969;58:116-20.
52. Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348:292-5.
53. Klassen TP, Sutcliffe T, Walters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr 1997;130:191-6.
54. De Boeck K, Van der Aa, N., Van Liercle S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis. A double blind dexamethasone efficacy study. J Pediatr 1997;131:919-21.
55. van Woensel JBM, Wolfs TFW, van Aalderen WMC, Brand PLP, Kimpen JLL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-7.
56. Berger I, Argaman Z, Schwartz SB, Segal E, Kiderman A, Branski D et al. Efficacy of corticosteroids in acute bronchioltis: short-term and long-term follow-up. Pediatr Pulmonol 1998;26:162-6.
57. Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 patients. Pediatrics 1999;104:77.
58. Garrison MM, Christiakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105:1-6.
59. Meissner HC, Fulton DR, Groothuis JR, Geggel RL, Marx GR, Hemming VG et al. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother 1993;37:1655-6.
60. Hemming VG, Rodriguez WJ, Kim HW, Brandt CD, Parrot RH, Burch B et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987;31:1882-6.
61. Groothuis JR, Simoes EAF, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ et al. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin. Antimicrob Agents Chemother 1995;39:668-71.
62. Hemming VG, Prince GA, Groothuis JR, Siber GR. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol Rev 1995;8:22-33.
63. Groothuis JR, Simoes EAE, Levin MJ, Hall CB, Long CE, Rodriguez WJ. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993;329: 1524-30.
64. Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics 1997;100:937-42.
65. Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 1997;99:454-61.
66. Rimensberger PC, Burek-Kozlowska A, Morell A, Germann D, Eigenmann AK, Steiner F et al. Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr Infect Dis J 1996;15:209-16.
67. The Impact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.